TruthArchive.ai - Related Video Feed

We received four Pfizer vaccines, and the one we sequenced is different from any previously analyzed. This may be an earlier version that Pfizer modified later. The vaccine contains a common plasmid used in coronavirus research, which raises questions about its origin. While Pfizer is the likely source, it's possible it leaked from a lab. We found similarities and differences in the components of the vaccines. The contamination hypothesis is unlikely since the plasmids have never been handled in our labs, and formalin fixation prevents spike protein production. Pfizer could have multiple undisclosed plasmids, which would be concerning, especially since we found one in a colon cancer sample that produces spike protein at high levels, indicating it could be replication competent and potentially transmissible. Transmissible cancer is a significant issue.

Pfizer did not disclose SV40 DNA in COVID vaccine to regulators, causing concern among Health Canada officials. The presence of SV40 DNA was confirmed by Pfizer but not shared with FDA, EMA, or HC initially. Despite claims that the DNA fragment is inactive and below regulatory limits, concerns remain about potential risks. Health Canada is working with international partners to address the issue for future vaccine strains. The focus seems to be on vaccine acceptance rather than addressing health risks associated with DNA contamination. Pfizer has not responded to requests for comment.

モデルナの配列は大腸菌で利用するビクター配列だが、ファイザーの配列にはSV40の配列の一部が含まれている。SV40は遺伝子の発現を上昇させるプロモーターだが、発がん性を持つウイルスとしても知られている。mRNAワクチン製造には全く不要な配列であり、なぜこのような配列があるのかが問題である。この配列があるとDNAが移行しやすくなり、ゲノムに入りやすくなる。SV40のプロモーターの中には核に移行する配列も入っている。試験管内でmRNAを合成するプロセスに全く関係ないSV40のプロモーター配列がなぜ残されているのかが疑問視されている。実験室ではよく使われるSV40プロモーターが、なぜmRNAワクチンに入っているのかが問題である。 **Translation:** Moderna's sequence uses a vector sequence common in E. coli, but Pfizer's sequence contains a portion of the SV40 sequence. SV40 is a promoter that increases gene expression but is also known as a carcinogenic virus. This sequence is completely unnecessary for mRNA vaccine production, and the question is why such a sequence is present. This sequence makes DNA more likely to migrate and enter the genome. The SV40 promoter also contains a sequence that migrates to the nucleus. The question is why the SV40 promoter sequence, which is completely unrelated to the process of synthesizing mRNA in vitro, remains. The SV40 promoter, which is often used in laboratories, is questioned as to why it is included in the mRNA vaccine.

Quan et al demonstrated that the introduction of DNA into a cell, even without integration, can trigger the oncogenic cGAS-STING pathway. The speaker claims that the presence of an SV40 origin of replication, a mammalian origin, in a vaccine grown in E. coli is reckless because it allows the plasmid DNA to replicate episomally in the host. The speaker alleges evidence suggests Pfizer, unlike Moderna, may have included this origin of replication due to carelessness. The speaker highlights concerns about nucleic acid persistence, noting that RT-PCR methods used in studies like Krausson and Rolchen may have amplified both DNA and RNA. The speaker suggests that prior studies assumed detected nucleic acids were RNA, but that further investigation using primers specific to the plasmid backbone might reveal the presence of residual plasmid DNA. The Krausson paper found nucleic acids present for thirty days in heart tissues, and the Rolchen paper found them for sixty days.

Every day, just the 1% of the cells of your DNA that gets replicated stretches from here to the sun four times. If you're to line it up end by end, that's very hard to conceptualize. But it should give you a little bit of humility before you go and start monkeying with it with these vaccines that can actually alter your DNA. And that's what I'm gonna show you. Is that the vaccines had a DNA contamination in them that didn't tell you about that could in fact alter your genome. Alright? These people are vibe coding your genome. And this is a major attack surface to the human gene pool because if this thing starts to alter the lifespan of people, it's going to part you with your Bitcoin. You're gonna end up spending money in a fiat system that has no controls, has no liability, and ends up oftentimes inducing mandates to get what it wants done. Many people had have peer have gone and replicated this work. It happened on Twitter. It did not happen very quickly in the peer review system. The peer review system kinda kicked it out. Some of these papers have now been peer reviewed, but it took years for them to come to this conclusion. Now, the FDA, the EMA and the TGA have all admitted that this mistake has happened. How did it happen? There's a big bait and switch. Pfizer actually ran the trial of 22,000 people on the process on the left and after they got to the trial, they then switched to the process on the right and didn't retrial the drug. And in doing so, they left a tremendous amount of excess DNA behind in the product. So all of the vaccine efficiency numbers you've heard in the news are flawed. They're not real because that's not what actually went into the trial. What went to the public was actually something that came out of this process too. It's published now in the BMJ that this fraud happened and no one has yet been prosecuted for it. So what did they leave in there? What they left in there was something we know from the polio scandal. If you're not familiar with the polio scandal, that polio vaccines were also contaminated with something known as SV40 and it created a massive cancer wave. Now the whole virus isn't in these vaccines, but there is a very curious part of this called the SV40 region that Pfizer intentionally removed from the disclosure that they gave to the FDA. So the FDA has admitted that this SV40 material is in there. They did not spell this out to the regulators. The regulators did not find them and they're actually running cover for them saying this DNA is too little consequence to matter, it's too small, and it's not functional. But we know it's functional because Dean et al has published that this piece of DNA drives DNA straight to the nucleus. It gets used in gene therapy vectors.

Speaker 0: I read the sequence and it's high-resolution. Speaker 1: It may seem low at first, but it's understandable. Speaker 0: This is written in a loop. Speaker 1: This is the genetic sequence of the spike protein. The issue is that the model RNA has a sequence that surprised me. We need to design it a bit. It contains part of the sequence SB4T, which is necessary for gene expression. The problem is that it is found in a virus that has negative effects. Also, there is another problem with this sequence. The DNA that has been transferred so far becomes more susceptible to mutation. It's a problematic point. Speaker 1: So, this SB4T sequence is also included in the promoter of this SB method, which allows it to migrate to the nucleus. Speaker 0: This is quite famous. Speaker 1: Yes, it is. The issue is that it has no relation to the process of synthesizing the messenger RNA. Speaker 0: Why did they keep the promoter sequence in the SB4T that has nothing to do with the camera's perspective in the messenger RNA synthesis process?

When COVID-19 vaccines were sequenced, commercial annotation software highlighted functional parts of the plasmids, including antibiotic resistance genes and SV40 components. The speaker claims that Pfizer had to manually remove these annotations before submitting the plasmid map to regulators. According to the speaker, regulators received the DNA sequence, but the sponsor is obligated to annotate every open reading frame and promoter, even if their function is unknown. The speaker alleges that Pfizer intentionally removed annotations, hiding them from the FDA, which the speaker believes is a violation of guidelines. The speaker suggests the reason for hiding SV40 components is due to SV40 virus contamination in polio vaccines and its debated link to cancer. The speaker asserts that while epidemiological data is confounded by vaccine shedding, laboratory studies show SV40 is a potent oncogenic virus. The speaker claims that the vaccines contain some of the more carcinogenic components of that virus, and that these sequences are functional and have consequences.

Pfizer was not initially ready for Operation Warp Speed. Pfizer allegedly went to their genetic department and found SV40, using it to design their COVID jab. They then allegedly instructed scientists to remove evidence of SV40 before presenting it to the FDA for approval. SV40, a monkey virus, appeared in polio vaccines during FDR's term and is now allegedly present in COVID vaccines seventy-five years later. There are two legal definitions for BioNTech and the Pfizer jab. In 2021, the speaker discussed a documentary with Robert Malone and Robert McCullough, highlighting two Pfizer patents. The speaker suspected in 2020 that SV40 would be used in someone's jab, most likely Pfizer's. The speaker advised people not to take the jab, especially the Pfizer jab.

Every vaccine maker except Pfizer was ready to deploy the COVID jab when Operation Warp Speed came out. Pfizer allegedly went to their genetic department and used SV40 to design their jab because they were behind. They then allegedly used a molecular tool to remove the evidence of SV40 before presenting it to the FDA for approval. SV40 was present in the Cutter incident during FDR's term in polio vaccines. The speaker questions how a monkey virus from 1951-1959 appears in COVID vaccines 75 years later, and claims Pfizer tried to remove it. The speaker believes the official story is that "they wanted to kill people." In 2021, the speaker discussed in a Clubhouse Bitcoin room a documentary with Robert Malone and Robert McCullough, focusing on two Pfizer patents. The speaker suspected in 2020 that SV40 would be used in a jab, most likely Pfizer's, and advised people not to take the Pfizer jab.

Many labs, including Medicinal Genomics, found DNA contamination in Pfizer and Moderna mRNA vaccines. Regulators like the FDA and EMA admitted to this, but downplayed its significance. The SP 40 sequences omitted by Pfizer are crucial. DNA contamination can cause insertional mutagenesis, as stated in Moderna's patents. Regulatory agencies were deceived and failed to properly address the issue. This poses a serious risk that cannot be ignored.

In this video, the speaker discusses concerns about the Pfizer vaccine and the regulatory process. They mention that the plasmid used in the vaccine was intentionally modified, and regulators are aware of this but have not taken action. The speaker also highlights a Moderna patent that suggests quantitative PCR undercounts DNA in the vaccines. They discuss the potential risks of DNA contamination and its impact on tumor suppressor genes. The speaker raises concerns about the FDA's revolving door culture and the need to screen the blood supply and fertility clinics. They mention studies showing the presence of nucleic acids in breast milk and raise questions about transplant organ issues and cancer biopsies. The speaker offers PCR primers for testing and encourages others to try it themselves.

Kevin McKernan, an experienced genomic expert, discusses his findings regarding mRNA vaccines. He discovered that the expression vectors for the vaccines, which are used to produce the spike protein, are still present in the vials. These vectors exceed the guidelines set by the EMA and FDA. McKernan explains the two different processes used in the clinical trials and how residual plasmids from E. coli amplification remain in the vaccines. He specifically highlights the presence of the SV40 promoter in Pfizer vaccines, which was not disclosed to the regulatory agencies. McKernan's team conducted quantitative PCR assays and found high levels of vector DNA in the vials. He emphasizes the importance of understanding the potential risks associated with this contamination and encourages others to replicate his work.

This video discusses concerns about informed consent and the presence of SV40 promoters in Pfizer vaccines. The speaker mentions Kevin McKernan's findings of plasmid DNA in the vials. Legal proceedings in Australia are mentioned, questioning the classification of these vaccine products. The speaker also talks about amyloidogenic sequences associated with viruses and their presence in SARS-CoV-2. They discuss a study on amyloidogenesis of the spike protein and how it could trigger amyloidogenic aggregation. The speaker highlights the increased attractiveness of the spike protein to neutrophil elastase due to added amino acids. They mention an analysis that shows similarities in amyloidogenic properties between the natural virus spike protein and the one translated in vaccine recipients. The video concludes with a mention of the cleavage of the spike protein and its potential implications.

The DNA sequence in gene therapy plasmids contains the SV40 promoter and enhancer region, an SV40 origin of replication, and an SV40 poly A signal. The SV40 enhancers are nuclear targeting sequences, ensuring the DNA enters the cell nucleus, especially during cell division when the nuclear envelope dissolves. Claims that it doesn't reach the nucleus are misleading. This plasmid was sourced from Pfizer's gene therapy department. The SV40 promoter and enhancer bind to the p53 gene, a tumor suppressor, which is concerning given that the spike protein also inhibits p53 expression. Literature indicates this sequence is a hypermutability element, inducing mutations in nearby DNA, suggesting potential tumorigenic activity. These findings contradict claims that this DNA has no function.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

Key points: "the vials that were in fact approved are not the vials that were given to the public." The clinical trial used "process one that used PCR to make the DNA that was going to then turn into the RNA to make the spike protein." After the trial, "they switched" to a production process that "manufactured this DNA in E. Coli," introducing endotoxin risk. "There are these plasmids that have additional DNA that were not present in the actual clinical trial." Sequencing found mixtures, including "expired" and samples that had "been tapped into." Regarding Pfizer, "the Pfizer vaccines actually had a component that was not disclosed to the regulators." "The plasmid map on the right is what was disclosed to the EMA" with "no mention of the SV40 components" now "inside this DNA sequence." "The plasma on the left is what we actually found," with components not disclosed to regulators nor to patients. Monovalent Pfizer; prior ones were the bivalent vaccines from Moderna and Pfizer.

The speaker discusses the finding of plasmids in Pfizer vaccines, referencing a widely read paper that initiated inquiry into the consequences of this residual contaminant. David Speaker replicated this work in Canada, finding it in every one of over 30 vials. Philip Buchholz replicated this in South Carolina, and Dr. Sid Lee replicated the work using different primers and Sanger sequencing. Bridget Koning has replicated this in Germany, and several federal agencies have admitted the presence of DNA, though disagreeing on clinical implications. Ulrich Kammerer's lab replicated the work, transfecting plasmids from the vaccines into cell lines, where they persisted for several cycles of cell division. High schoolers interning at the FDA White Oak facility also measured it and found it to be significantly over the limit. Numerous studies have replicated these findings, with most finding levels over the limit. One individual with ties to Moderna claims it is not over the limit. Kaiser et al. claimed to have found it slightly over the limit but deemed it inconsequential; however, their DNA isolation method has been refuted by Kommer and Konig.

Pfizer's use of the RiboGreen technique to measure DNA in their vaccines has raised concerns about deceptive practices. The presence of billions of DNA fragments in each dose, some of which are small and more likely to integrate into the genome, is worrying. Preliminary data suggests a correlation between adverse events and contaminated Pfizer vaccines, but more research is needed. The DNA in the vaccines is different from previous contamination and carries a higher risk of integration. The FDA acknowledges the integration risk and the need for lower limits on DNA when copy numbers are high. The DNA is encapsulated in lipid nanoparticles, making it prothrombotic and potentially oncogenic. The presence of endotoxin and the spike protein in the vaccines further complicates the situation. The vaccines have been found in various tissues and can lead to prolonged expression of the spike protein. Insertional mutagenesis and cancer risk are concerns, especially for individuals with weakened immune systems. Regulatory bodies have confirmed the presence of the SV40 sequence in the vaccines, but the clinical implications are still unclear.

The initial regulatory response claimed the DNA fragment was too small to matter, but this was based on an assumption without measurement. The quantity of DNA is now shown to be over the limit, especially considering lipid nanoparticles, even if the limit were justifiable. Claims that the DNA is non-functional are also incorrect. The DNA sequence includes the SV40 promoter and enhancer region, as well as an SV40 origin of replication.

"Pfizer vaccine is contaminated with plasma DNA. It's not just mRNA." "This DNA is the DNA vector that was used as the template for the in vitro transcription reaction when they made the mRNA." "I sequenced it in my own lab." "The vials of Pfizer vaccine that were given out here in Colombia, one of my colleagues was in charge of that vaccination program in the College of Pharmacy." "And for reasons that I still don't understand, he kept every single vial." "So he had a whole freezer full of the empty vials." "And I checked these two batches, and I checked them by sequencing." "It's surprising that there's any DNA in there." "This DNA, in my view, it could be causing some of the rare but serious side effects like death from cardiac arrest."

Health Canada initially claimed the Pfizer vaccine did not contain SV40, but later acknowledged its presence, stating it has no functional role. Despite this, they sought clarification from Pfizer about the residual fragments. When asked for information, Health Canada provided redacted documents, raising questions about transparency. A technique called fluorometry, which labels DNA with fluorescent markers, revealed that some RNA vaccines, particularly Moderna's, could contain up to 10 trillion copies of DNA fragments per dose. This is concerning because just 3 to 10 copies can facilitate the incorporation of SV40 DNA into a cell's nuclear genome, potentially leading to mutations associated with cancer.

The speaker states they found four pieces of the virus, not the whole virus. The pieces found include the SV40 origin of replication, the SV40 promoter, the SV40 enhancer, and part of the poly A signal. The speaker claims David Dean published that the SV40 enhancer is a nuclear targeting sequence. Therefore, claims that it will not reach the nucleus are inaccurate. The speaker asserts the presence of the SV40 origin of replication, a mammalian origin of replication, means it will replicate inside mammalian cells. The speaker believes regulators need to consider this risk.

A peer-reviewed paper confirms Pfizer's mRNA vaccine is contaminated with dangerous DNA and SV40 enhancers. During production, bacterial plasmid DNA led to contamination with spike protein genes, antibiotic resistance markers, and SV40 enhancers. Researchers found four to five times more DNA than the safe limit; these DNA fragments could integrate into the human genome due to the SV40 enhancer. Experiments showed the vaccines were toxic to cells, causing pathological changes and spike protein production, potentially spreading body-wide via exosomes. The DNA contamination, tucked into lipid nanoparticles, could lead to unintended gene therapy. The SV40 enhancer, deliberately added but removed from regulatory paperwork, raises questions about Pfizer's intentions. Experts theorize this contamination could be linked to an increase in "turbo cancers," coinciding with Pfizer's acquisition of a cancer drugmaker. An epidemiologist noted the study found DNA from the manufacturing process way over regulatory limits, including the cancer-promoting SV40 promoter enhancer and spike-producing DNA. A separate study found vaccine spike protein expressed in cerebral arteries of stroke patients for up to seventeen months, potentially contributing to autoimmune responses. There are now 11 independent reports that have found, DNA contamination within these shots of up to 60000% above regulatory limits.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The video discusses the presence of SV40 (simian virus 40) in COVID genetic vaccines and its potential link to cancer. The speaker clarifies that while the vaccines do not contain the entire virus, they do contain the promoter and enhancer from SV40, which could increase the risk of DNA integration and potential oncogenesis. The speaker also mentions the role of lipid nanoparticles in vaccine delivery and the need for further research on their toxicity. Additionally, concerns are raised about the biodistribution of the vaccines and their potential impact on the germline. The speaker emphasizes the importance of understanding these risks and considering alternative approaches to respiratory virus vaccination.